These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Low-weight molecular dextran]. Larcan A; Calamai M; Camez AM Coeur Med Interne; 1970 Jan; 9(1):79-90. PubMed ID: 5512919 [No Abstract] [Full Text] [Related]
3. [Prevention of postoperative thrombosis with low molecular weight dextran. Apropos of a series using a radioactive isotope technic]. Houel F; Farhathaidar A; Rasolomala R; Mercier C Anesth Analg (Paris); 1976; 3(4):593-6. PubMed ID: 1015646 [No Abstract] [Full Text] [Related]
4. [Use of light molecular weight Dextran for prevention of postoperative thrombosis in urologic surgery]. Moine C; Archimbaud JP Lyon Med; 1969 Jul; 222(30):214-9. PubMed ID: 5398728 [No Abstract] [Full Text] [Related]
5. The dextrans--clinical data. Thorén L Dev Biol Stand; 1980; 48():157-67. PubMed ID: 6168501 [TBL] [Abstract][Full Text] [Related]
6. Acute pulmonary edema associated with use of low-molecular weight dextran for prevention of microvascular thrombosis. Kitziger KJ; Sanders WE; Andrews CP J Hand Surg Am; 1990 Nov; 15(6):902-5. PubMed ID: 1702797 [TBL] [Abstract][Full Text] [Related]
7. Experimental arterial thrombus prevention and renal function in sheep after infusion with low molecular weight dextran and dextran 70,000. Hunt PS; Reeve TS Ann Surg; 1967 Jul; 166(1):51-8. PubMed ID: 6028842 [No Abstract] [Full Text] [Related]
8. Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits. Matthiasson SE; Lindblad B; Mätzsch T; Holst J; Bergqvist D Thromb Haemost; 1994 Mar; 71(3):363-5. PubMed ID: 7518099 [TBL] [Abstract][Full Text] [Related]
9. [Use of law molecular weight dextran for prevention of thrombosis in surgical patients (review of the literature)]. Sukhanov AA; Sukhanov VA Khirurgiia (Mosk); 1976 Oct; (10):133-5. PubMed ID: 1022932 [No Abstract] [Full Text] [Related]
10. An assessment of the potential use of anionic dextrans as a plasma substitute. Chang RL; Crawford MP; West MD J Biomed Eng; 1980 Jan; 2(1):41-4. PubMed ID: 7359897 [TBL] [Abstract][Full Text] [Related]
11. Dextran-induced anaphylactoid reactions. Report of two cases. Dobloug I J Oslo City Hosp; 1974 Jun; 24(6):75-7. PubMed ID: 4851351 [No Abstract] [Full Text] [Related]
13. [Experiences with antithrombotic effect of postoperatives dextran 70 000 infusions (author's transl)]. Ott W Schweiz Rundsch Med Prax; 1975 Aug; 64(32):1032-4. PubMed ID: 1161750 [No Abstract] [Full Text] [Related]
14. Measurement and control of quality determining properties of clinical dextrans. Nilsson K Dev Biol Stand; 1980; 48():169-77. PubMed ID: 6168502 [TBL] [Abstract][Full Text] [Related]
15. [Death caused by infusion of low-molecular dextran]. Plamieniak L; Kowal-Gierczak B; Kotschy M; Kurzawska M; Kozlowska B Wiad Lek; 1974 May; 27(10):901-5. PubMed ID: 4839858 [No Abstract] [Full Text] [Related]
17. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran. Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157 [No Abstract] [Full Text] [Related]
18. Arterial thrombus prevention and dissolution after low molecular weight dextran infusion in sheep. Hunt PS; Reeve TS Med J Aust; 1967 Mar; 1(11):539-41. PubMed ID: 6023810 [No Abstract] [Full Text] [Related]
19. [Anaphylactoid reactions after dextran infusion]. Aanderud L; Gran L Tidsskr Nor Laegeforen; 1975 Nov; 95(33):1896-7. PubMed ID: 1188899 [No Abstract] [Full Text] [Related]